Marc Giroux is the founder and owner of KurveTx, a medical device company developing the Vianase® platform. KurveTx focuses on intranasal delivery technology designed to enable targeted administration of compounds to the central nervous system. Marc leads product development, strategy, and clinical collaboration related to the Vianase device. His work sits at the intersection of engineering, translational science, and clinical application. He brings an industry and innovation perspective to discussions on novel therapeutic delivery approaches.
Marc Giroux
CEO, Kurve Therapeutics
United States of America